Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 26, 2026
Reporting period
Not applicable
Filed with the SEC
May 27, 2026
CEOIndirect holdingGift / transfer
Context
Classification
gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001106578-26-000061
Filed / recorded
May 27, 2026, 12:44 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Martine A Rothblatt
Relationship
Director, Officer
Officer title
Chairperson & CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 26, 2026
Transaction code
G
Shares / units
9,009
Acquired / disposed
Disposed (D)
Shares owned after
249,108
Ownership form
Indirect — by Trust
Amendment
No
Footnotes from the filing
Bona fide gift of shares
Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.